Tests washed microbiota transplantation for diabetic stomach and gut movement problems
Tests washed gut bacteria transplant in adults with diabetes-related digestive movement disorders.
Plain-language title generated from the registry record
Registry title: Washed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Safety Study
Key facts
- Where
- Nanjing, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT06340828, who can take part
Where in China
- The Second Affiliated Hospital of Nanjing Medical UniversityNanjing, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The Second Hospital of Nanjing Medical University
- Trial code
- NCT06340828
- Record updated
- 3 April 2024
- Original description
The goal of this clinical trial is to learn about effectiveness and safety of washing microbiota transplantation in diabetic gastrointestinal motility disorders participant population. The main questions it aims to answer are:Read full original descriptionShow less
Washed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Safety Study
The goal of this clinical trial is to learn about effectiveness and safety of washing microbiota transplantation in diabetic gastrointestinal motility disorders participant population. The main questions it aims to answer are:
* The risk factors of diabetic gastrointestinal motility disorders in routine clinical data or biochemical tests. * The composition of gut microbiota in diabetic gastrointestinal motility disorders patients and potential pathogenic bacteria. * The efficacy of washing microbiota transplantation in the clinical treatment of diabetic gastrointestinal motility disorders patients and potential factors that may influence treatment outcomes. * The potential mechanisms of washing microbiota transplantation in treating diabetic gastrointestinal motility disorders patients.
Participants will be collected fasting venous blood and random stool samples before treatment and at week 12 post-treatment, conducting scale assessments before treatment and at weeks 1, 4, and 12 post-treatment.
Inclusion: Clinical diagnosis of type 2 diabetes and diabetic gastrointestinal motility disorder; Glycated hemoglobin (HbA1c) < 11.0%.
Exclusion: Insulin dependent diabetes; Active infections, antibiotics-using, inflammatory bowel disease, irritable bowel syndrome, or other severe gastrointestinal organic disease; Thyroid disease, malignancies, severe cognitive impairment and mental disease; Severe diabetic complications; Alcohol or substance abuse; Pregnancy or lactation.